Good Day BIO Newsletter

We’re heading to San Francisco for the BIO Investor Forum—you can follow the action all week long right here in your inbox and at Bio.News. Meanwhile, we look at how 340B could be improved and how biotech is boosting food security. (813 words, 4 minutes, 3 seconds)

We’ve got lots to cover this week—including what to expect on Mexico’s corn ban, what Sen. Bill Cassidy MD said about FDA’s Orange Book, and more news on price controls and bird flu. (871 words, 4 minutes, 21 seconds)

Ending the month with three things you need to know about sepsis, and how the Senate is working to advance sustainable aviation fuel (SAF)—plus, the latest news on avian flu and COVID vaccine benefits. (637 words, 3 minutes, 11 seconds)

This couldn't wait for Monday. We have an exclusive interview with Sen. Todd Young on biosecurity, plus good news about Centers for Medicare and Medicaid Services (CMS) rules governing drug rebates in Medicaid. (668 words, 3 minutes, 20 seconds)

Today we have BIO’s new podcast episode on national security and more news you need to know. (824 words, 4 minutes, 7 seconds)

A busy week in Washington brought progress on Pediatric Disease Priority Review Voucher (PPRV) reauthorization and conversations on price controls. Plus, BIO names Virginia Gov. Glenn Youngkin Governor of the Year. (790 words, 3 minutes, 57 seconds)

We’re packing a lot into one little newsletter: a new poll that shows strong bipartisan support for boosting American biomanufacturing, a House antitrust hearing on PBMs, and a lot more news you need to know to start your week. (762 words, 3 minutes, 48 seconds)

We’re back on a Tuesday, with news about the Rare Pediatric Disease Priority Review Voucher program and the BIOSECURE Act—plus, the season opener of the I am BIO Podcast. (725 words, 3 minutes, 37 seconds)

With Valley fever cases on the rise, we look at the latest news on vaccines for pets and people. Plus, exclusive interviews with the winners of the Start-Up Stadium at the 2024 BIO International Convention and more news you need to know as Congress returns from recess. (756 words, 3 minutes, 46 seconds)

Back to work after the summer holidays—and today, we’re looking at the latest news on human and animal vaccines, plus how the “maximum fair prices” for the first 10 medicines targeted under the Inflation Reduction Act (IRA) renews concerns about the law’s negative impact on innovation. (733 words, 3 minutes, 39 seconds)